Clinical efficacy and correlation with tumor PD-L1 expression in patients (pts) with melanoma (MEL) treated with the anti-PD-1 monoclonal antibody MK-3475 Meeting Abstract
| Authors: | Kefford, R.; Ribas, A.; Hamid, O.; Robert, C.; Daud, A.; Wolchok, J. D.; Joshua, A. M.; Hodi, F. S.; Gangedher, T. C.; Hersey, P.; Weber, J. S.; Dronca, R. S.; Patnaik, A.; Zarour, H. M.; Dolled-Filhart, M.; Lunceford, J.; Emancipator, K.; Ebbinghaus, S.; Rang, S. P.; Hwu, W. J. |
| Abstract Title: | Clinical efficacy and correlation with tumor PD-L1 expression in patients (pts) with melanoma (MEL) treated with the anti-PD-1 monoclonal antibody MK-3475 |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202897 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.3005 |
| Notes: | Meeting Abstract: 3005^ -- Source: Wos |
